Letrozole: A Powerful Treatment for Breast Cancer

Started by daisymiller, Mar 25, 2025, 01:32 AM

Previous topic - Next topic

daisymiller

Letrozole is an oral medication belonging to the class of aromatase inhibitors, widely used for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogen. By reducing estrogen levels, Letrozole helps slow down or stop the growth of estrogen-dependent breast cancer cells.

This medication is commonly prescribed as part of adjuvant therapy following surgery or as a treatment for metastatic breast cancer. In addition to its cancer-fighting properties, Letrozole is sometimes used off-label for ovulation induction in women with fertility issues, particularly those with polycystic ovary syndrome (PCOS).

Letrozole is available in 2.5 mg tablets and is generally well-tolerated, though some patients may experience side effects such as hot flashes, fatigue, joint pain, and bone thinning. Regular medical supervision is essential to monitor bone health and overall treatment effectiveness.

Due to its efficacy and affordability, Letrozole has become a preferred choice for oncologists worldwide. Its availability in generic form ensures that patients have access to a cost-effective solution for breast cancer treatment, significantly improving survival rates and quality of life. A reputable Letrozole Manufacturer plays a crucial role in ensuring a consistent supply of high-quality medication to meet global healthcare needs.